Delivery Order SPE2DB24D2205-SPE2DB25FDXBB

Award Date 1/17/25
Potential Completion Date 1/21/25
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of NAYZILAM 5 MG NASAL SPRAYS to the U.S. government. The contract, valued at $1,344.52, is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). Amerisourcebergen is a major pharmaceutical distribution company that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,424.41 firm fixed-price delivery order is for the supply of NAYZILAM 5 MG NASAL SPRAYS, with a performance period ending on March 17, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of NAYZILAM 5 MG NASAL SPRAYS. The contract is a firm fixed-price delivery order with a ceiling value of $1,974.49 and a period of performance through February 26, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which...
This federal contract award, valued at $1,674.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NAYZILAM 5 MG NASAL SPRAYS and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,724.31, is for the delivery of NAYZILAM 5 MG NASAL SPRAYS. This is a firm fixed-price delivery order contract with a period of performance through March 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award is a delivery order valued at $2,168.72 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of NAYZILAM 5 MG NASAL SPRAYS, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of March 7, 2025 and is a firm fixed-price type. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,464.07 firm-fixed-price delivery order is for the supply of NAYZILAM 5 MG NASAL SPRAYS, a medication used for the treatment of seizures. The contract has an ultimate completion date of December 11, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $2,086.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the provision of NAYZILAM 5 MG NASAL SPRAYS, a medical product. This is a Delivery Order contract with a Firm Fixed Price pricing type, and the ultimate completion date is March 10, 2025. The contract award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,158.44 firm fixed-price delivery order is for the supply of NAYZILAM 5 MG NASAL SPRAYS, a pharmaceutical product. The contract has an ultimate completion date of November 15, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,820.87, is for the delivery of NAYZILAM 5 MG NASAL SPRAYS and has a completion date of September 21, 2023. The contract is a delivery order, with a firm fixed-price pricing type. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDXBB
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,043.25, is for the delivery of NAYZILAM 5 MG NASAL SPRAYS.

The contract is a Firm Fixed Price Delivery Order without any set-aside requirements, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 4/18/25, 1:56 PM